Abstract Dental stem cells, especially dental follicle cells (DFCs) as precursor cells for the periodontium have interesting prospects for regenerative dentistry. During periodontitis, butyrate as a bacterial metabolite and inflammatory agent is often found in millimolar concentrations in periodontal pockets. This study evaluates the effects of butyrate on the proliferation and osteogenic differentiation of DFCs. We assessed cell viability/proliferation (BCA assay) and osteogenic differentiation (ALP activity, alizarin staining and RT PCR) of DFCs in vitro after butyrate supplementation. Butyrate concentrations of 20 mM or higher are toxic for DFCs. At a non-toxic concentration, butyrate promotes the expression of alkaline phosphatase and collagen type-1 but inhibits the formation of calcified nodules and the induction of RUNX2 and osteocalcin under osteogenic differentiation conditions. In conclusion, DFCs are resistant to physiological high concentrations of butyrate. Butyrate facilitates the osteogenic differentiation of DFCs in early stages but inhibits calcification at later stages of the differentiation process.
Introduction
Periodontitis is a bacterial infection of the connective tissue surrounding the dental root and the main cause for tooth loss [1] . After the initial infiltration of bacteria into the periodontal pocket, an immunological response is triggered by the presence of virulence factors such as carboxylic acids, lipopolysaccharides (LPS), proteases and other immune-modulatory molecules such as interleukins. The response, mediated by mono-and lymphocytes, leads to an irreversible loss of periodontal tissue [2] . One important virulence factor is butyrate (butyric acid), a member of the short-chain carboxylic acid family. Butyric acid is a major metabolic product of Gram-negative periodontopathic bacteria such as Porphyromonas, Prevotella, and Fusobacterium and is released in millimolar concentrations. It is known to play an important role in the etiology of periodontal diseases [3] . Butyrate is commonly found in dental plaque [4] and gingival crevicular fluid in a concentration correlated to the severity of the periodontal infection [5] . Several studies have shown that butyrate exhibits antiproliferative properties on human pulp fibroblasts [6] , B-and T-cells [7] and colon cancer cells [8] . It can also suppress [9] or stimulate [10] osteoblastic differentiation in a dose-dependent manner. Butyrate alters the expression of genes responsible for growth arrest, differentiation, and apoptosis by inhibiting the histone deacetylase in many different cell lines [11, 12] . Current research on this topic shows varying results depending on cell type; however, no research has been done on dental stem/progenitor cells such as dental follicle cells (DFCs).
DFCs have multi-potent differentiation capabilities and could be promising for future clinical approaches in the treatment of periodontal diseases. The dental follicle is a loose connective tissue of ectomesenchymal origin surrounding the developing tooth germ. It plays an important role in tooth development and its eruption process [13] . DFCs express typical mesenchymal stem cell markers such as STRO-1, CD13, CD44, and CD73, and they are capable to differentiate into neural-, adipocyte-, periodontal ligament-, and cementoblast/osteoblast-like tissue cells [14, 15] . However, DFCs also have unique characteristics different from mesenchymal stem cells, for example a soft matrix but not a rigid matrix supports the osteogenic differentiation of these cells [16] .
Since a conventional treatment only inhibits the progression of periodontitis, a therapy is highly welcome, which supports the regeneration of the periodontium [17] [18] [19] . The progress in dental stem cell research discovered their ability to modulate the immune response [20] . This effect combined with their multi-potent differentiation potential makes DFCs an interesting source for cellular therapies of periodontal tissues.
In contrast to other oral cell types such as gingival fibroblasts, DFCs are only little exposed to bacterial stimuli such as butyrate. Moreover, our previous study has shown that DFCs responded differently to the exposure of LPS than other oral cell types (e.g. PDL fibroblasts) [21] . However, the reaction of DFCs on treatment with butyrate (sodium butyrate: NaB) is still unknown. Therefore, this study investigated the viability/proliferation and the osteogenic differentiation of DFCs after treatment with NaB.
Materials and methods

Cell culture
The DFCs were isolated previously [21] . Briefly, the attached dental follicle was separated from the developing root of an impacted third molar [15] with the informed consent of the patient. The follicle was separated from the tooth, the dental papilla tissue was discarded, and the cells were minced and digested in a solution of 0.1 U/ml collagenase type I and 1 U/ml dispase (Roche, Mannheim, Germany) for 1 h at 37°C. Plastic adherent spindlelike cells (Fig. 1a) were cultured in MesenchymStem Medium (PAA, Pasching, Austria) until confluence, before being passaged and seeded at a density of 5000 cells/cm 2 . Medium changes occurred every two to three days. For osteogenic differentiation, the StemPro Osteogenic Differentiation Kit (Invitrogen, Darmstadt, Germany) was used. For experiments, cells were used between the passages 4-6.
DFCs were analyzed for stem cell-associated markers with flow cytometry for characterization of anti-CD105-APC (1/10 dilution) (130-094-926, Miltenyi Biotec, Bergisch Gladbach, Germany), anti-CD44-FITC (1/10 dilution) (130-095-195, Miltenyi Biotec, Bergisch Gladbach, Germany), and anti-nestin-PE (1/21 dilution) (IC1259A, R&D systems, Minneapolis, MN USA). Singlecell suspensions of DFCs were incubated with monoclonal antibodies for 45 min at 4°C, washed once in PBS with 2 nM EDTA and 0.5 % BSA. For intracellular staining (nestin) DFCs were permeabilized with 0.5 % saponin and 0.5 % BSA for 15 min and washed once in PBS with 2 nM EDTA and 0.5 % BSA before staining with anti-nestin antibody. Immunoglobulin G (IgG) isotype-matched control (Miltenyi Biotec) was used as negative control. Flow cytometry analyses were done using the FACS Canto II (Becton-Dickinson, Heidelberg, Germany). Isolated DFCs express markers CD105, CD44, and nestin (Fig. 1b) .
BCA protein assay (cell viability/proliferation) A BCA protein assay (ThermoScientific, Massachusetts, USA) was used to determine the amount of protein in the wells, which corresponds to the amount of vital adhering cells. Cells were seeded at a density of 5000 cells/cm 2 in a 48-well plate and given 24 h to adhere before being treated with varying concentrations of NaB (Sigma Aldrich, Munich, Germany). After 24 and 72 h, the cells were washed with PBS and lysed with 25 ll of 0.1 % Triton-X 100. 200 ll of the BCA reagent was added and plates were incubated at 37°C for 30 min. Subsequently the protein concentration was measured at 540 nm.
WST-1 assay (cell viability)
The WST-1 assay (Roche, Mannheim, Germany) was applied to determine the amount of viable cells. The cells were seeded at a density of 5000 cells/cm 2 in a 96-well plate and given 24 h to adhere. They were then exposed to different concentrations of NaB. After 24 h, the WST-1 reagent was added to the cells according to the manufacturer's manual and incubated for 4 h before being evaluated in a spectrophotometer at 450 nm.
Osteogenic differentiation
DFCs were seeded at 5000 cells/cm 2 in cell culture dishes as described above. At sub confluence, the medium was changed and an osteogenic differentiation medium (StemPro Ost. Diff. Kit, Invitrogen, Darmstadt, Germany), supplemented with or without 0.2 mM NaB was used.
For the alkaline phosphatase (ALP) activity quantification (day 7 and day 14 of differentiation), DFCs were washed with PBS and then lysed in 40 ll of Triton-X 100. 15 ll of the lysate was used for DNA concentration measurement, which was done with the quantIT dsDNA Kit (Invitrogen, Darmstadt, Germany) according to manufacturer's protocol. The remaining 25 ll was used to measure ALP concentration by adding 25 ll alkaline buffer (Sigma Aldrich) and 42 ll phosphatase substrate (Sigma Aldrich). After 30 min of incubating the experiment at 37°C, the reaction was stopped by adding 42 ll of 0.3 M NaOH and the optical density was measured at 405 nm. The DNA quantification results were used to correlate the individual ALP activity to the amount of cells in each well.
DFCs at day 21 of differentiation were used for alizarin red staining. Cells were washed with PBS, fixed with 70 % acetone and stained with alizarin red. The formation of calcified nodules was analyzed under a microscope. For quantitative analysis, the alizarin staining was lysed with cetylpyridinium-chloride-monohydrate and the optical density was measured at 570 nm.
Quantitative real-time polymerase chain reaction (qRT-PCR) mRNA was isolated after 7 days of osteogenic differentiation to assess changes in the expression of known osteogenic markers. The cells were cultured for differentiation as described above. After 7 days, RNA was isolated with the RNEasy Kit (Qiagen, Hilden, Germany) according to the manufacturer's protocols. The subsequent reverse transcription of 1 lg RNA into cDNA was done using the QuantiTect Reverse Transcription Kit (Qiagen, Hilden, Germany). qRT-PCR reactions were performed using the LightCycler Ò FastStart DNA Master PLUS SYBR Green I Kit or the LightCycler Ò TaqMan Ò Master (Roche, Mannheim, Germany). The LightCycler 2.0 was used for thermocycling. Primers are listed in Table 1 . The expression of the housekeeper gene GAPDH was used as reference for measurements. The DDC t calculation method was applied to evaluate the relative quantity of gene expression. (Fig. 1a) were positive for CD105, CD44, and nestin (Fig. 1b) .
Results
FACS analysis showed that the isolated cells
The cell proliferation under the influence of butyrate was measured after 24 and 72 h. No significant decrease of cell proliferation was determined at concentrations up to 2 mM (Fig. 2) . However, the number of adhering cells was significantly decreased at concentrations of 20 mM and higher. After 72 h, only 10 % of cells survived at 200 mM of NaB. The estimated lethal concentration 50 (LC50) was between 100 and 200 mM (Fig. 2) . Our results with the BCA assay were confirmed with a WST1 assay (Fig. 3) .
For the osteogenic differentiation experiments, the osteogenic differentiation medium was supplemented with a NaB concentration of 0.2 mM to avoid any toxic effects of NaB on DFCs. After 7 days, ALP activity in the treated cells was slightly but not significantly decreased as compared to the positive control group. However, the ALP activity in NaB-treated cells was significantly increased after 14 days, if compared with the osteogenic differentiation group without NaB (Fig. 4) . After 21 days of differentiation, a calcium accumulation was detectable after alizarin red staining in the positive controls and treated cells; however, the mineralization was significantly diminished in the group with NaB-treated DFCs (Fig. 5) . The qRT-PCR after 7 days of NaB treatment showed significant changes for the expression of ALP and collagen type-1. However, the expression of Osteocalcin and Runx2 was not induced (Fig. 6 ).
Discussion
We analyzed the cell proliferation rate and the osteogenic differentiation of DFCs in this study to evaluate the impact of NaB on cellular therapies with DFCs. NaB is a major component of dental plaque and dental crevicular fluid with concentrations ranging from 0.2 to 2.8 mM [4, 5] . It is also an inhibitor of the histone deacetylases (HDACs), influencing genes responsible for proliferation, apoptosis, and differentiation [11, 12] . In our viability/proliferation assays, we found that NaB starts to affect proliferation rates at a concentration of 20 mM with an LC50 of more than 100 mM after 72 h. However, our data suggest also that DFCs are more resistant to NaB than other cell types. In a study with periodontal ligament fibroblasts, the cell proliferation rate was severely inhibited at a concentration of 1 mM NaB [22] . Studies on gingival epithelial cells, skin epithelial cells, porcine epithelial rests of Malassez, and dental pulp fibroblasts showed a 50 % decrease of cell growth rates at concentrations of 1, 1, 4, and 16 mM, respectively [6, 23, 24] . One explanation for the resistance of DFCs could be the location (niche) and the highly undifferentiated state of DFCs. For example, gingival epithelial cells and periodontal ligament cells have a more differentiated state and they are located in close vicinity to oral bacteria. This could make them more sensitive to the administration of NaB. In contrast to the proliferation of DFCs, NaB affects the osteogenic differentiation of DFCs at low concentrations. We determined the ALP activity, the mineralization and the expression of known osteogenic differentiation markers such as collagen type-1 (COL-1), Runx2, and Osteocalcin (OCN). The enzymatic activity of ALP is important for the crystallization of hydroxyapatite, and it is therefore a decisive factor for the osteoblastic differentiation [25] . We found that 0.2 mM NaB induces the ALP activity after 14 days of differentiation while the mineralization was inhibited after 21 days of differentiation. The gene expression of early differentiation markers such as collagen type-1, and ALP was significantly up-regulated after 1 week of differentiation, while the expression of late markers OCN and Runx2 were constitutively expressed. Morozumi et al. [9] found that NaB inhibits osteoblastic differentiation and nodule formation by down-regulation of Runx2, Osterix, Dlx5, Msx2, and ALP activity in ROS17/ 2.8 cells. However, Katono et al. [10] reported that NaB stimulated osteogenic differentiation of osteoblasts. Interestingly, NaB increases also the ALP activity in preosteoblastic cells but not in mature osteoblastic cells [26] . Results of these studies suggest that the influence of NaB on the osteogenic differentiation depends on the concentration and on the type of the osteogenic precursor cells. In our study, the biomineralization of DFCs was decreased while ALP activity was increased. This could be due to the failed induction of OCN and Runx2 as important factors for the biomineralization. However, further studies on molecular mechanisms are required to explain the effect of NaB on DFCs.
In conclusion, DFCs can withstand higher NaB concentrations than other oral cell types of previous studies. Interestingly, a low NaB concentration stimulates the ALP activity and COL-1 expression during osteogenic differentiation, but inhibits the biomineralization. The natural location and the undifferentiated state of DFCs could be an explanation for this result, but further studies are required to prove this hypothesis. 
